UPDATE THE UNITARY PATENT SYSTEM 30 TH NOVEMBER 2018

Similar documents
Unitary patent system

Lundbeck s view on the EU IP systems

SUMMARY OF THE IMPACT ASSESSMENT

1. 3. Advantages and disadvantages of using patents as an indicator of R&D output

Unitary patent & Unified Patent Court

Unitary Patent & Unified Patent Court

Building a foresight system in the government Lessons from 11 countries

Getting The Most from Your IP Budget: Strategies for IP Portfolio Management And Litigation Avoidance. March 4, 2009

PATENT PROTECTION IN FRANCE

Patents, trade and foreign direct investment in the European Union

Counterfeit, Falsified and Substandard Medicines

Ref: Overview of the implementation of the TRIPS Agreement (patents) in the EPC contracting states and observer countries

Journey towards success: From idea to market a real case study. Dr. Wolfram Meyer Malta

What s in the Spec.?

Filing strategies in Europe

Patents in Europe 2018/2019. Helping business compete in the global economy. Litigating patents under the UPC system

Unitary Patent Package Conference 2016

JOINT STATEMENT POSITION PAPER. List of Goods and Services 512 characters restriction. 10 February 2016

Algae Biomass Summit 2014: Patent Strategies for Algae Companies in an Era of Patent Reform Peter A. Jackman, Esq. October 2, 2014

Henning Sejer Jakobsen

Aleksandar Stojkov, PhD Spring 2016

I3U Getting Good Ideas to Market Final Conference September 25, 2018

Keynote Speech. at the. Trilateral User Conference "CHALLENGES FACING THE GLOBAL PATENT SYSTEM"

IP and Technology Management for Universities

FICPI views on a novelty grace period in a global patent system

IP KEY SOUTH EAST ASIA ANNUAL WORK PLAN FOR 2018

The role of Intellectual Property (IP) in R&D-based companies: Setting the context of the relative importance and Management of IP

WIPO LIST OF NEUTRALS BIOGRAPHICAL DATA

Second medical use claims The pregabalin litigation in Europe IMK seminar at Awapatent, 18 May 2017

WIPO NATIONAL WORKSHOP FOR PATENT LAWYERS

Litigation Funding for Patent Disputes

IP support and IP strategy development in the Austrian innovation system plus a brief look at Switzerland and Ireland

Google reveal. their secret to a successful IP Litigation strategy. Catherine Lacavera, Director of IP and Litgation, Google

INTERNATIONAL PATENT F O R U M M A R C H , L O N D O N T H E W A L D O R F H I L T O N H O T E L

UNCITRAL Third International Colloquium on Secured Transactions Session on Contractual Guide on IP Licensing (Vienna, March 3, 2010)

1. Introduction. defining and producing new materials with advanced properties, or optimizing industrial processes.

Settlement of Pharma Disputes and Competition Law in Korea

The TTO circle workshop on "Technology Transfer in Nanotechnology"

WIPO Sub-Regional Workshop on Patent Policy and its Legislative Implementation

5 th Annual Pharma IPR Conference 2016

IPR in the EU 2011, 2012, 2013, By Jesper Kongstad Director General, CEO The Danish Patent and Trademark Office

TRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY ACCESS TO MEDICINE: Exploitation of pharmaceutical patents: compulsory licences SESSION 4

Answer to Community Patent Consultation To:


The ETV pilot programme: State of play, standardisation issues

Patents and other Intellectual Property. Carl Otto Barth ABACUS Patentanwälte Klocke Späth Barth Adliswil/Zürich (CH) + Horb/Neckar (DE)

Unitary patent & Unified Patent Court

Pro IPLIFESCIENCES. MEDIA KIT 2015

BIOPIRACY: FACT OR FICTION? INTERNATIONAL TREATY NEGOTIATIONS COULD AFFECT YOUR IP RIGHTS AND YOUR BOTTOM LINE

Protect your ideas. An introduction to patents for students of natural sciences, engineering, medicine and business administration

The Uneasy Future of Software and Business-Method Patents

Robotics, AI and the Law

Patent Working Requirements Historical and Comparative Perspectives

IP, STRATEGY, PROCEDURE, FTO Peter ten Haaft (PhD, Dutch and European Patent Attorney)

Recommendation Regarding a National Strategy for Intellectual Property. Background. 6 June 2013

Finnish STI Policy

Getting the Most From Your IP Budget: Strategies for IP Portfolio Management and Litigation Avoidance

Licensing, Transfer of Ownership and Dispute Resolution - Commercialization of Intellectual Property Generated in International R&D Projects

University IP and Technology Management. University IP and Technology Management

(3) How does one obtain patent protection?

OECD s Innovation Strategy: Key Findings and Policy Messages

Flexibilities in the Patent System

October 4 6, Session IX. The legal Problems arising from Auctioning of IPRs. Saturday, October 6, to p.m.

Whole of Society Conflict Prevention and Peacebuilding

Outline of Patent Attorney Act and Its History of Revisions for Further Improving the Quality of Patent Attorneys in Japan

OFSET. Organization for Free Software in Education and Teaching. Bagneux, March 31, Our answer to the EU consultation on patents in Europe

Intellectual property governance and strategic value creation:

Commonwealth Data Forum. Giovanni Buttarelli

Patent application strategy when, where, what to file?

Rosatom Approach to IPR Management in Collaborative Projects on Innovations

IP Commercialization Trends Income or Impact. Trieste, September 29 and 30, 2016

2018 Chem- Pharma- Biotech Highlights on Patentability and Patent Infringement

GENEVA INTERGOVERNMENTAL COMMITTEE ON INTELLECTUAL PROPERTY AND GENETIC RESOURCES, TRADITIONAL KNOWLEDGE AND FOLKLORE

Contrasting Reorganization Systems: How Reorganization Work Around the World

Patentability of Computer-Implemented Inventions in the field of Computer Security

Research DG. European Commission. Sharing Visions. Towards a European Area for Foresight

Architectural Design Process

UNIVERSAL SERVICE PRINCIPLES IN E-COMMUNICATIONS

DEFENSIVE PUBLICATION IN FRANCE

Afternoon Seminar on. The Swedish Patent and Market Courts (PMD/PMÖD) experiences and observations on the first year s operation, and

Fig. 1: Trend in patent applications for the top five offices. Dr.-Ing. Edgar Jochheim 1

Managing your IP in Medical and Pharmaceutical Industry in China and South-East Asia

BUSINESS PLAN CEN/TC 290 DIMENSIONAL AND GEOMETRICAL PRODUCT SPECIFICATION AND VERIFICATION EXECUTIVE SUMMARY

Claus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team

Building a Competitive Edge: Protecting Inventions by Patents and Utility Models

KADOR & PARTNER. Kador & Partner invites you to an advanced training course on European Patent Law in Munich

PATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY

Sapna W. Palla. New York:

Patients Must Have Immediate Access to Affordable Generic Medicines at Day One After Patent Expiry

CRC Association Conference

POST EVENT REPORT IP Life Sciences Exchange 2015

Intellectual Property Management - How to capture, protect and exploit your ideas

Topic 2: Patent Families

SHORT SUMMARY REPORT OF THE WORKSHOP ON GENETIC INVENTIONS, INTELLECTUAL PROPERTY RIGHTS AND LICENSING PRACTICES

Agreements in R&D and Technology Transfer: Best Practices and Model Agreements

Director General, WYSE Travel Confederation. PH welcomed all participants and stated that quorum was present and called the meeting to order.

Standing Committee on the Law of Patents

THE ECONOMICS OF DATA-DRIVEN INNOVATION

International development

EBLIDA submission to the European Commission Consultation: Europeana: next steps

Transcription:

UPDATE THE UNITARY PATENT SYSTEM 30 TH NOVEMBER 2018

AGENDA 1. Zacco in brief 2. Reform of the European Patent System 3. Implications for Companies 4. If time - Industry 4.0 and Patenting 2 Zacco 2018

ZACCO - EUROPEAN FOOTPRINT INTERNATIONAL NETWORK Full-service European IP consultancy with Scandinavian roots 360 o approach to IP Classical Legal Instruments, Cyber Security, Digital Brands, Data and Digital Assets More than 472 employees 29 offices in Denmark, Sweden, Norway, Germany, Great-Britain, France and India Founded in 1870 3 Zacco 2018

REFORM OF THE EUROPEAN PATENT SYSTEM 4 Zacco 2018

THE EPC AND THE PATENT REFORM The European Patent Convention of 1973 Intergovernmental agreement establishing the European Patent Organisation not an European Union institution - and managed by the Administrative Council Establish the European Patent as a supplement to Paris-route applications to national offices European patents are validated in European countries and thus form a Bundled patent of national rights with the same origin and legal capacity European patents are inforced in national juristictions Ever since the entery in to force of the EPC, attempts has been made to establish a common enforcement system - but to no avail until 2012 5 Zacco 2018

WHY THE REFORM CREATING THE UP AND THE UPC? As IP becomes decisive for Company Value:. a strong political desire emerged to create a European-wide enforcement system being an integrale part of the European patent system, that: Are cost-efficient and less time consuming Avoids (or reduce) forum shopping Establish one single set of Rules of Procedures, and That ensure a high and uniform quality of enforcement by having a shared pool of judges with equivalent education and traning 6 Zacco 2018

POLITICAL COMPROMISE AND -DECION DANISH PRESIDENCY OF THE EU Political compromise reached in December 2012 by agreement between the European Council and the European Parlaiment Elements from the German system of bifocation (separation of validity and infringment issues) and North European practise of oral procedings The court can be set at national, regional and central level, thus allowing contracting states to keep proximity to users 7 Zacco 2018

IMPLEMENTATION REMAINING ISSUES AND WAY FORWARD The UP/UPC will enter in to force when 13 contracting states has ratifyed including the UK, France and Germany Today, 16 stats has ratifyed including France and the UK Two issues: 1. A constitutional complaint is filed in Germany no information as to when and whether this will be clarifyed 2. If the Agreement is not entered in to force before 29. March 2019 (day of Brexit), elements of the deal has to be renegotiated 8 Zacco 2018

PROJECTION The Optimist Germany is expected to clarify the constitutional issues within 6. mth. i.e. June 2019 Re-negotiate UK participation - 6. mth. towards the end 2019 Ratification in the beginning of 2020 End Preliminary Application Periode (PAP) June 2020 and UP/UPC up-and-running year end 2020 The Pessimist Additional two years negotiating UK participation and location of central devisions bio-banche Up-and-running 2022 or later 9 Zacco 2018

IMPORTANT TO CONSIDER OPT-OUT? IF AND WHEN In the PAP of four month from the last ratification until Sun-rise applicants can opt-out with the right to opt-in later After sun-rice, applicants can opt-out, unles their application is part of an ongoing legal prociding. Anglo-American pharma and biotech companies are expected to opt-out undtil practise has been established with the new UPC Similar considerations in other industries European and national patents will prevail in the short and medium term 10 Zacco 2018

INDUSTRY 4.0 AND THE PATENT SYSTEM.. IF TIME PERMITS 11 Zacco 2018

INDUSTRY 4.0 AND THE PATENT PROCESS Idea Prepare and file applicati on Investigate & search Draft application Authority process applicati on Search Evaluate Dialogue between authority and advisor Patent grant Renewal fees Red circles indicate that processes are disrupted 12 Zacco 2018

13 Zacco 2018 THANK YOU FOR YOUR ATTENTION